9,419 Shares in Colgate-Palmolive Company $CL Acquired by Marble Wealth LLC

Marble Wealth LLC acquired a new position in shares of Colgate-Palmolive Company (NYSE:CLFree Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 9,419 shares of the company’s stock, valued at approximately $744,000.

Several other institutional investors have also recently modified their holdings of the stock. Kesler Norman & Wride LLC raised its position in shares of Colgate-Palmolive by 6.6% during the 4th quarter. Kesler Norman & Wride LLC now owns 16,699 shares of the company’s stock worth $1,320,000 after purchasing an additional 1,041 shares during the last quarter. Peak Retirement Planning Inc. raised its position in shares of Colgate-Palmolive by 20.3% during the 4th quarter. Peak Retirement Planning Inc. now owns 26,955 shares of the company’s stock worth $2,130,000 after purchasing an additional 4,551 shares during the last quarter. Dynasty Wealth Management LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $540,000. Natixis Advisors LLC raised its holdings in Colgate-Palmolive by 12.2% in the 4th quarter. Natixis Advisors LLC now owns 354,199 shares of the company’s stock valued at $27,989,000 after acquiring an additional 38,548 shares during the last quarter. Finally, New Mexico Educational Retirement Board raised its holdings in Colgate-Palmolive by 1.1% in the 4th quarter. New Mexico Educational Retirement Board now owns 37,030 shares of the company’s stock valued at $2,926,000 after acquiring an additional 400 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 3.8%

Shares of NYSE CL opened at $84.95 on Thursday. The firm has a fifty day moving average of $86.41 and a 200-day moving average of $85.86. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The stock has a market capitalization of $67.98 billion, a PE ratio of 33.05, a P/E/G ratio of 4.58 and a beta of 0.33.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same period in the prior year, the company earned $0.91 EPS. The firm’s revenue was up 8.4% on a year-over-year basis. On average, analysts anticipate that Colgate-Palmolive Company will post 3.82 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were given a dividend of $0.53 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend was Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Analyst Ratings Changes

Several brokerages have weighed in on CL. Barclays boosted their price target on Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, May 5th. Bank of America cut their price target on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a report on Friday, April 10th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. UBS Group boosted their price objective on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Finally, Weiss Ratings raised shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $95.88.

Read Our Latest Stock Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.